Last reviewed · How we verify

NCT03960320

Health Related Quality of Life of Patients With Abdominal Wall Defects

Completed Last updated 23 May 2019
What this trial tests

trial testing questionnaire in Quality of Life in 65 participants. Completed in 31 December 2015.

Timeline
1 May 2014
Primary endpoint
31 December 2015
31 December 2015

Quick facts

Lead sponsorUniversität des Saarlandes
StatusCompleted
Study typeOBSERVATIONAL
Enrollment65
Start date1 May 2014
Primary completion31 December 2015
Estimated completion31 December 2015

Drugs / interventions tested

Conditions studied

Sponsor

Universität des Saarlandes — full company profile →

Who can join

Adults 1 Day to 40, any sex, with Quality of Life or Abdominal Wall Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Examination of the health-related quality of life of patients operated on due to congenital defects of the abdominal wall after birth with the questionnaires KINDL, SDQ and SF-36.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Universität des Saarlandes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03960320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing